Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Crowdsourcing to Promote HBV and HCV Testing in China [NA]
The UNC-Chapel Hill-sponsored trial NCT03482388, a crowdsourcing initiative to promote HBV and HCV testing in China, has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study [Phase 2]
Phase 2 study evaluating the safety and antiviral effect of experimental drugs in combination with peginterferon alfa-2a and ribavirin in pe…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir [Phase 3]
A Phase 3 trial in Egyptian children and adolescents with Hepatitis C genotype 4 evaluated the combination of Sofosbuvir and Daclatasvir; th…
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents [Phase 3]
Phase 3 trial update evaluating the safety and efficacy of the fixed-dose combination sofosbuvir/ledipasvir in adolescents with chronic hepa…
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital [NA]
A completed clinical trial update comparing hepatitis C care and treatment delivery in primary health care settings versus a tertiary hospit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Impact of Antiviral Therapy on Gastroesophageal Varices.
A completed clinical trial update evaluating the impact of antiviral therapy on gastroesophageal varices in chronic hepatitis C patients wit…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks
This trial update reports on the effectiveness and safety outcomes of an eight-week regimen combining Paritaprevir, Ombitasvir, Ritonavir, a…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: SMV + SOF With/Without RBV for IFN-II Patients With CHC [Phase 4]
Phase 4 trial evaluating the combination of simeprevir and sofosbuvir, with or without ribavirin, in interferon-experienced chronic hepatiti…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India
This clinical trial update reports on the safety and efficacy of sofosbuvir-based regimens for chronic hepatitis C infection in real-world p…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) [Phase 3]
Phase 3 trial EXPEDITION-2 evaluated ABT-493/ABT-530 for efficacy and safety in adults with chronic hepatitis C virus genotype 1-6 infection…
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
A Gilead registry update describing outcomes for subjects who did not achieve sustained virologic response in chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1 [Phase 3]
Clinical trial update indicating completion of a Phase 3 study of Sofosbuvir, Ledipasvir, and Ribavirin for genotype 1 hepatitis C in patien…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection [Phase 1]
A Phase 1 clinical trial of an HCV entry inhibitor in liver transplant recipients with hepatitis C infection has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Hepatitis C (HCV) Cure and Kidney Health
A clinical trial update on Hepatitis C cure and kidney health outcomes sponsored by the San Francisco Veterans Affairs Medical Center.
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies [Phase 3]
Phase 3 trial evaluating ledipasvir/sofosbuvir with or without ribavirin in hepatitis C patients who failed prior sofosbuvir-based therapy; …
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: The Pathogenesis of Hepatitis C Virus Vertical Transmission
A completed clinical trial exploring the pathogenesis of vertical transmission of Hepatitis C virus from mother to child.
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2) [Phase 3]
Phase 3 study evaluating ABT-493/ABT-530 in adult transplant recipients with chronic hepatitis C completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection [Phase 1]
Phase 1 trial update evaluating sofosbuvir-containing regimens without interferon for acute hepatitis C infection, including participants wi…
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: Pilot Trial of Directly Observed Anti HCV Therapy & Contingency Management in a Population on Opiate Substitute Therapy [NA]
A completed pilot clinical trial evaluating directly observed anti-Hepatitis C therapy with contingency management in people on opiate subst…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection [Phase 3]
This Phase 3 study evaluating daclatasvir and sofosbuvir with ribavirin in patients with cirrhosis and genotype 3 hepatitis C has completed,…
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) [Phase 2]
This phase 2 trial evaluated a fixed-dose combination of grazoprevir, uprifosbuvir, and ruzasvir in chronic hepatitis C patients who failed …
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients [Phase 4]
A Phase 4 trial update reports on sofosbuvir-containing regimens for chronic hepatitis C infection, genotype 2.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients [Phase 3]
Phase 3 trial evaluating sofosbuvir-containing regimens for chronic hepatitis C virus infection genotype 3 has completed enrollment and stat…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients [Phase 2, Phase 3]
Completed Phase 2 and Phase 3 clinical trials evaluating the combination of sofosbuvir and daclatasvir in Chinese patients with treatment-ex…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection [Phase 3]
A Phase 3 trial evaluated a fixed-dose combination of ledipasvir/sofosbuvir given for 12 weeks in adults with chronic genotype 2 HCV infecti…